Evolution and Validation 0f Practice Standards, Training, and Professional Development
Patient Care
Essential:
β’
Rounding with interdisciplinary team
β’
Assists with informed pharmacotherapy decisions
β’
Provision of drug information to the critical care team
β’
Provision of drug therapy education to critical care team
β’
Assists with prevention of inappropriate drug therapy
β’
Provides clinical consultation for pharmacotherapeutic issues related to critical illness
β’
Medication consults are available 24 hr/d, 7 d/wk
β’
Provision of pharmacokinetic monitoring and therapeutic adjustments for targeted drugs
β’
Review of medication history for determination if maintenance therapy should be continued
β’
Medication reconciliation services for ICU patients upon admission, transfer, and discharge
β’
Prospective review of all orders for verification of appropriateness
β’
Patient and/or caregiver medication therapy education
β’
Performance of independent patient assessments, e.g., pain/agitation, delirium, nutrition
β’
Response to cardiac life support by ACLS certified pharmacists 24 hr/d, 7 d/wk
β’
Response to other resuscitation and time-dependent emergencies in the hospital
β’
Provision of stewardship of antimicrobials and other selected medications
β’
Collaboration with other pharmacists within the hospital as needed
β’
Provision of nutrition therapy plan and modifications in concert with clinical dieticians
β’
Use of medical record for communication with other healthcare professionals
β’
Documentation of patient care and economic impact of services
β’
Documentation of all clinical activities
β’
Pharmacy liaison with other interdisciplinary team members relative to medication policies, procedures, guide-
lines, and pathways
β’
Utilizes pharmacoeconomic analyses to evaluate new critical care pharmacotherapeutic agents
β’
Proactive in designing, prioritizing, and promoting new clinical pharmacy programs
β’
Evaluation of clinical pharmacy services for stakeholder satisfaction, significance, and economic value
β’
Participation in planning preparedness and implementation of processes for disaster and mass casualties
β’
Majority of time dedicated to critical care services
β’
Patient care time devoted to care of the critically ill patients
β’
Decentralized clinical services 24 hr/d
β’
Development of critical care pharmacist βteamsβ
β’
Appropriate pharmacist-to-patient ratio based on patient acuity and complexity
Desirable:
β’
Provision of medication management problems documentation of progress notes daily
β’
Preparation and presentation of drug monographs to the P&T Committee
β’
Provision of telemedicine services if onsite critical care pharmacists are absent